BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15625688)

  • 1. Caloric restriction transiently improves motor performance but hastens clinical onset of disease in the Cu/Zn-superoxide dismutase mutant G93A mouse.
    Hamadeh MJ; Rodriguez MC; Kaczor JJ; Tarnopolsky MA
    Muscle Nerve; 2005 Feb; 31(2):214-20. PubMed ID: 15625688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient caloric restriction in early adulthood hastens disease endpoint in male, but not female, Cu/Zn-SOD mutant G93A mice.
    Hamadeh MJ; Tarnopolsky MA
    Muscle Nerve; 2006 Dec; 34(6):709-19. PubMed ID: 16941656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caloric restriction shortens lifespan through an increase in lipid peroxidation, inflammation and apoptosis in the G93A mouse, an animal model of ALS.
    Patel BP; Safdar A; Raha S; Tarnopolsky MA; Hamadeh MJ
    PLoS One; 2010 Feb; 5(2):e9386. PubMed ID: 20195368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of diet on adenosine monophosphate-activated protein kinase activity and disease progression in an amyotrophic lateral sclerosis model.
    Zhao Z; Sui Y; Gao W; Cai B; Fan D
    J Int Med Res; 2015 Feb; 43(1):67-79. PubMed ID: 25534414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
    Cervetto C; Frattaroli D; Maura G; Marcoli M
    Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis.
    Mahoney DJ; Rodriguez C; Devries M; Yasuda N; Tarnopolsky MA
    Muscle Nerve; 2004 May; 29(5):656-62. PubMed ID: 15116368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of p53: no effect in a transgenic mouse model of familial amyotrophic lateral sclerosis.
    Kuntz C; Kinoshita Y; Beal MF; Donehower LA; Morrison RS
    Exp Neurol; 2000 Sep; 165(1):184-90. PubMed ID: 10964497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS.
    Haenggeli C; Julien JP; Mosley RL; Perez N; Dhar A; Gendelman HE; Rothstein JD
    Neurobiol Dis; 2007 Apr; 26(1):146-52. PubMed ID: 17276077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial deficiency of manganese superoxide dismutase exacerbates a transgenic mouse model of amyotrophic lateral sclerosis.
    Andreassen OA; Ferrante RJ; Klivenyi P; Klein AM; Shinobu LA; Epstein CJ; Beal MF
    Ann Neurol; 2000 Apr; 47(4):447-55. PubMed ID: 10762155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
    Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
    Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of peripheral nerve injury on disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Sharp PS; Dick JR; Greensmith L
    Neuroscience; 2005; 130(4):897-910. PubMed ID: 15652988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure to an environmental neurotoxicant hastens the onset of amyotrophic lateral sclerosis-like phenotype in human Cu2+/Zn2+ superoxide dismutase 1 G93A mice: glutamate-mediated excitotoxicity.
    Johnson FO; Yuan Y; Hajela RK; Chitrakar A; Parsell DM; Atchison WD
    J Pharmacol Exp Ther; 2011 Aug; 338(2):518-27. PubMed ID: 21586603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cu/Zn superoxide dismutase (SOD1) mutations associated with familial amyotrophic lateral sclerosis (ALS) affect cellular free radical release in the presence of oxidative stress.
    Cookson MR; Menzies FM; Manning P; Eggett CJ; Figlewicz DA; McNeil CJ; Shaw PJ
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Jun; 3(2):75-85. PubMed ID: 12215229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyruvate slows disease progression in a G93A SOD1 mutant transgenic mouse model.
    Park JH; Hong YH; Kim HJ; Kim SM; Kim MJ; Park KS; Sung JJ; Lee KW
    Neurosci Lett; 2007 Feb; 413(3):265-9. PubMed ID: 17174029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice.
    Holasek SS; Wengenack TM; Kandimalla KK; Montano C; Gregor DM; Curran GL; Poduslo JF
    Brain Res; 2005 May; 1045(1-2):185-98. PubMed ID: 15910777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memantine prolongs survival in an amyotrophic lateral sclerosis mouse model.
    Wang R; Zhang D
    Eur J Neurosci; 2005 Nov; 22(9):2376-80. PubMed ID: 16262676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS.
    Hall ED; Andrus PK; Oostveen JA; Fleck TJ; Gurney ME
    J Neurosci Res; 1998 Jul; 53(1):66-77. PubMed ID: 9670993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
    Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
    Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No benefit of dietary restriction on disease onset or progression in amyotrophic lateral sclerosis Cu/Zn-superoxide dismutase mutant mice.
    Pedersen WA; Mattson MP
    Brain Res; 1999 Jun; 833(1):117-20. PubMed ID: 10375685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HoxB2 binds mutant SOD1 and is altered in transgenic model of ALS.
    Zhai J; Lin H; Canete-Soler R; Schlaepfer WW
    Hum Mol Genet; 2005 Sep; 14(18):2629-40. PubMed ID: 16079151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.